Skip to main content

Advertisement

SpringerLink
Log in

Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Activation of coagulation and fibrinolysis is frequently found among cancer patients. Such tumors are considered to be associated with a higher risk of invasion, metastases, and eventually, worse outcome. The aim of this study is to explore the clinical and prognostic value of blood coagulation tests in gastric cancer (GC) patients.

Materials and Methods

A total of 44 consecutive patients with a pathologically confirmed diagnosis of GC were enrolled into the study. Pretreatment blood coagulation tests including prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), D-dimer (DD), fibrinogen (F) levels, and platelet (PLT) counts were evaluated. Control group comprised 50 age- and sex-matched individuals without history of malignancy and coagulation disorder.

Results

Median age at diagnosis was 55 years, range 19–80 years; most had men (n = 32, 73 %) and metastatic disease (n = 31, 70 %). The level of blood coagulation tests showed a statistically significant difference between the patient and the control groups (P < 0.001 for all, but p = 0.07 for PT). DD levels were significantly associated with elevated PLT and LDH levels (p = 0.009 and p = 0.01, respectively). Patients with metastatic disease had higher levels of F (p = 0.001) and INR (p = 0.027) levels. Elevated DD levels tended to be a poor prognostic factor on outcome (p = 0.06).

Conclusion

Change in almost all coagulation tests are found in GC patients and only DD level seems to be of prognostic value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lyman GH, Khorana AA. Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol. 2009;27:4821–6.

    Article  PubMed  CAS  Google Scholar 

  2. Dvorak HF. Thrombosis and cancer. Hum Pathol. 1987;18:275–84.

    Article  PubMed  CAS  Google Scholar 

  3. Kessler CM. The link between cancer and venous thromboembolism: a review. Am J Clin Oncol. 2009;32:S3–7.

    Article  PubMed  Google Scholar 

  4. Khorana AA. Risk assessment and prophylaxis for VTE in cancer patients. J Natl Compr Canc Netw. 2011;9:789–97.

    PubMed  CAS  Google Scholar 

  5. Langer F, Holstein K, Eifrig B, Bokemeyer C. Haemostatic aspects in clinical oncology. Hämostaseologie. 2008;28:472–80.

    PubMed  CAS  Google Scholar 

  6. Falanga A, Marchetti M, Vignoli A, Balducci D. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Clin Adv Hematol Oncol. 2003;1:673–8.

    PubMed  Google Scholar 

  7. Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31:388–94.

    Article  PubMed  CAS  Google Scholar 

  8. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97:1158–64.

    Article  PubMed  CAS  Google Scholar 

  9. Siegel R, Naishadam D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  10. Kovacova E, Kinova S, Duris I, Remkova A. General changes in hemostasis in gastric cancer. Bratisl Lek Listy. 2009;110:215–21.

    PubMed  CAS  Google Scholar 

  11. Rahr HB, Sørensen JV, Larsen JF, Jensen FS, Bredahl C. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy. Scand J Gastroenterol. 1994;29:516–21.

    Article  PubMed  CAS  Google Scholar 

  12. Yamamura T. Hematological disorders in patients with gastric cancer. Nihon Geka Gakkai Zasshi. 1984;85:675–85.

    PubMed  CAS  Google Scholar 

  13. Di Micco P, Romano M, Niglio A, Nozzolillo P. Alteration of haemostasis in non-metastatic gastric cancer. Dig Liver Dis. 2001;33:546–50.

    Article  PubMed  Google Scholar 

  14. Fidan E, Kavgaci H, Orem A, Yilmaz M. Thrombin activatable fibrinolysis inhibitor and thrombin–antithrombin-III-complex levels in patients with gastric cancer. Tumour Biol. 2012;33:1519–25.

    Article  PubMed  CAS  Google Scholar 

  15. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009;27:4834–8.

    Article  PubMed  CAS  Google Scholar 

  16. Palumbo JS, Degen JL. Fibrinogen and tumor cell metastasis. Haemostasis. 2001;31 Suppl 1:11–5.

    PubMed  CAS  Google Scholar 

  17. Eisenhauera EA, Therasseb P, Bogaertsc J, Schwartzd LH, Sargente D, Fordf R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  Google Scholar 

  18. Tramecere I, Negri E, Pelucchi C. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23:28–36.

    Article  Google Scholar 

  19. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1038 patients. Ann Surg. 2000;232:362–71.

    Article  PubMed  CAS  Google Scholar 

  20. Glimelius B, Ekstrom K, Hoffman K. Randomised comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163–8.

    Article  PubMed  CAS  Google Scholar 

  21. Falanga A. Thrombophilia in cancer. Semin Thromb Haemost. 2005;31:104–10.

    Article  Google Scholar 

  22. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: trousseau's syndrome revisited. Blood. 1983;62:14–31.

    PubMed  CAS  Google Scholar 

  23. Bottasso B, Mari D, Coppola R, Santoro N, Vaglini M, Mannuci PM. Hypercoagulability and hyperfibrinogenemia in patients with melanoma. Thromb Res. 1996;81:345–52.

    Article  PubMed  CAS  Google Scholar 

  24. Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, Kobayashi H. Prognostic significance of plasma D-dimer levels in patient with lung cancer. Thorax. 1997;52:563–5.

    Article  PubMed  CAS  Google Scholar 

  25. Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18:600–8.

    PubMed  CAS  Google Scholar 

  26. Szajda SD, Darewicz B, Gorzel M, Zalewska B, Skrzydlewski Z, Kudelski J, et al. Cancer procoagulant (CP). Przegl Lek. 2005;62:169–72.

    PubMed  Google Scholar 

  27. Molnar S, Guglielmone H, Lavarda M, Rizzi ML, Jarchum G. Procoagulant factors in patients with cancer. Hematology. 2007;12:555–9.

    Article  PubMed  CAS  Google Scholar 

  28. Naito S, Inoue S, Kinjo M, Tanaka K. Thromboplastic and fibrinolytic activities of cultured human gastric cancer cell lines. Gann. 1983;74:240–7.

    PubMed  CAS  Google Scholar 

  29. Rickles FR, Shoji M, Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. J Hematol. 2001;73:145–50.

    CAS  Google Scholar 

  30. De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004;50:187–96.

    Article  PubMed  Google Scholar 

  31. Connoly GC, Khorana AA. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb Res. 2010;125:1–7.

    Article  Google Scholar 

  32. Südhoff T, Schneider W. Fibrinolytic mechanisms in tumor growth and spreading. Clin Invest. 1992;70:631–6.

    Article  Google Scholar 

  33. Tiutrin II, Karpov AB, Udut VV, Tsisik RM, Solokhina EA. Disorders of the hemostatic system in patients with disseminated stomach cancer. Vopr Onkol. 1989;35:460–5.

    PubMed  CAS  Google Scholar 

  34. Abbasciano V, Tassinari D, Sartori S, Trevisani L, Arcudi D. Usefulness of coagulation markers in staging of gastric cancer. Cancer Detect Prev. 1995;19:331–6.

    PubMed  CAS  Google Scholar 

  35. Prokopowicz J, Gabryelewicz A, Wołosowicz N, Szałaj W, Puchalski Z. Peripheral and gastric fibrinolysis in patients with gastric carcinoma. Z Exp Chir. 1975;8:309–12.

    PubMed  CAS  Google Scholar 

  36. Kwon HC, Oh SY, Lee S, Kim SH. Plasma levels of prothrombin fragment F1 + 2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol. 2008;38:2–7.

    Article  PubMed  Google Scholar 

  37. Mkrtchian LN, Shukurian SG, Sarkisian OM, Magakian AG. Blood coagulation disorders and tumor growth. Vopr Onkol. 1991;37:992–7.

    PubMed  CAS  Google Scholar 

  38. Wojtukiewicz MZ, Sierko E, Zacharski LR, Zimnoch L, Kudryk B, Kisiel W. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer. Semin Thromb Hemost. 2003;29:291–300.

    Article  PubMed  CAS  Google Scholar 

  39. Pavlovskiĭ DP. Disseminated intravascular coagulation syndrome (DIC) in stomach and intestinal cancer. Vopr Onkol. 1986;32:37–42.

    PubMed  Google Scholar 

  40. Heimburger N, Pâques EP, Römisch J. Coagulation and fibrinolysis in cancer. Behring Inst Mitt. 1992;91:169–82.

    PubMed  Google Scholar 

  41. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem. 2008;15:923–9.

    Article  PubMed  CAS  Google Scholar 

  42. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001;86:828–33.

    PubMed  CAS  Google Scholar 

  43. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol. 2003;72:1–7.

    Article  PubMed  Google Scholar 

  44. Nierodzik ML, Klepfish A, Karpatkin S. Role of platelets, thrombin, integrin IIb–IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost. 1995;74:282–90.

    PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Institute of Oncology, University of Istanbul, Istanbul, Turkey

    Faruk Tas, Rumeysa Ciftci, Leyla Kilic, Murat Serilmez, Senem Karabulut & Derya Duranyildiz

Authors
  1. Faruk Tas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rumeysa Ciftci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leyla Kilic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Serilmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Senem Karabulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Derya Duranyildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faruk Tas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tas, F., Ciftci, R., Kilic, L. et al. Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer. J Gastrointest Canc 44, 285–292 (2013). https://doi.org/10.1007/s12029-013-9490-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-013-9490-x

Keywords

Search

Navigation